Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Gabapentin May Not Raise the Risk of Falling After All - 16 days ago Novel Agent Reduces Monthly Migraine Days - 5 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 10 months ago Novel Drug Approved for All Duchenne Muscular Dystrophy Variants - 10 months ago
2	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Neumora’s antidepressant stumbles in first Phase 3 trial readout - 20 days ago STAT+: Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results - 23 days ago
3	Kristen Monaco MedPage Today	Cymbalta Bottles Recalled; 1 in 3 Older Adults Are Lonely; Walking Off Depression - about 1 month ago Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy - 3 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 6 months ago Digital Therapies Compared; Summertime Sadness? Spravato Monotherapy Under Review - 6 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 11 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug - about 1 month ago
5	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves New Option for Rosacea - 3 months ago Cheap Antidepressant Flops for Severe Breathlessness in Trial - 4 months ago FDA Approves First Oral Option for Eosinophilic Esophagitis - 11 months ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Dupilumab Proves Effective in Chronic Spontaneous Urticaria - 3 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 4 months ago
7	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More Context - 3 months ago
8	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	This Drug Shows Potential to Stop Migraines Before They Begin - 4 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 4 months ago FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 4 months ago FDA Accepts New Drug Application for Suzetrigine to Manage Acute Pain - 6 months ago Celltrion USA Submits Biologics License Application for CT-P39, a Biosimilar to Xolair - 10 months ago Study: Belumosudil Decreased Collagen, IL-17 Levels for Skin, Oral cGVHD - 11 months ago Results Show Dupilumab Reduces Airway Inflammation In Asthma - 11 months ago Extended-Release Buprenorphine Found Well-Tolerated for Fentanyl Opioid Use Disorder - about 1 year ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago
10	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	FDA Reviewers Skeptical of Ocaliva for Rare Bile Duct Disease - 4 months ago

Journalists covering duloxetine